For more information, contact J. Patrick Elliott, VP Business Development, Terumo Cardiovascular Systems, (734) 741-6061.
Acquisition Summary:1. Target Company
Harvest Technologies Corporation 2. Purchase Price
*Maximum $35 million for milestone payment during the period 2012 through 2015
$70 million3. Financing
Cash on hand4. Change in Harvest shares held by TerumoBefore the acquisition: 0%
After the acquisition: 100%5. Closing date
April 29, 2011Corporate Profile of Harvest Technologies Corporation:1. Name
Harvest Technologies Corporation 2. Representative
Gary Tureski (President & CEO)3. Established
19974. Head Office
Massachusetts, USA5. Main Activities
Manufacture and distribution of devices and kits for PRP and BMAC harvesting6. No. of Employees
61 (as of December 2010)7. Sales
$25.9 million (as of December 2010)Impact on esultsThe impact of legal or regulatory proceedings and accounting for acquisition on Terumo's financial results will be disclosed as and when determined.
About Terumo CorporationTerumo Corporation is a premier global medical device company with annual sales of more than 3.4 billion dollars for the fiscal year ending March 31, 2010. Founded in 1921, the company develops, manufactures and distributes world-class medical devices, such as syringes, blood bags and IV solutions. Terumo has the biggest share of the world markets for angiography guide wires and perfusion products and is a leading developer of interventional products, such as catheters and stents. For mo
|SOURCE Terumo Americas Holding, Inc.|
Copyright©2010 PR Newswire.
All rights reserved